CPK-MB test

The CPK-MB test is a blood test used to measure the level of the MB isoenzyme of Creatine kinase (CK) in the blood. This test is primarily used to diagnose myocardial infarction (heart attack) and to assess the extent of heart muscle damage.

Diagram showing blood tests used in diagnosing acute myocardial infarction, including CPK-MB.

Background

Creatine kinase is an enzyme found in various tissues, including the heart, brain, and skeletal muscle. It plays a crucial role in energy production by catalyzing the conversion of creatine and utilizing adenosine triphosphate (ATP) to create phosphocreatine and adenosine diphosphate (ADP). CK has three isoenzymes: CK-MM, CK-BB, and CK-MB. The CK-MB isoenzyme is predominantly found in cardiac muscle, making it a useful marker for heart muscle damage.

Clinical Use

The CPK-MB test is particularly useful in the context of acute coronary syndrome (ACS) and suspected myocardial infarction. When heart muscle is damaged, as in the case of a heart attack, CK-MB is released into the bloodstream. Measuring the levels of CK-MB can help determine the presence and severity of a myocardial infarction.

Procedure

The test involves drawing a blood sample from a vein, usually in the arm. The blood is then analyzed in a laboratory to measure the concentration of CK-MB. Elevated levels of CK-MB in the blood can indicate heart muscle damage.

Interpretation

- Normal Range: The normal range for CK-MB is typically 0-5 ng/mL, but this can vary slightly depending on the laboratory. - Elevated Levels: Elevated CK-MB levels suggest myocardial damage. Levels typically rise within 4-6 hours after a heart attack, peak at 12-24 hours, and return to normal within 48-72 hours.

Limitations

While the CPK-MB test is useful, it is not as specific as newer markers such as troponin. CK-MB can also be elevated in conditions other than myocardial infarction, such as myocarditis, pericarditis, and muscular dystrophy.

Related Pages

• Myocardial infarction
• Creatine kinase
• Troponin
• Acute coronary syndrome